Multivariable logistic regression analysis on risk factors for lymph node metastasis in the whole cohort
| Variable . | OR (95% CI) . | P-Value . |
|---|---|---|
| Race | ||
| Other versus white | 0.802 (0.502–1.280) | 0.355 |
| Histology | <0.001 | |
| B3 versus A + AB + B1 + B2 | 3.616 (1.729–7.563) | 0.001 |
| TCs versus A + AB + B1 + B2 | 8.536 (4.569–15.950) | <0.001 |
| TNETs versus A + AB + B1 + B2 | 39.844 (18.803–84.430) | <0.001 |
| T stage | ||
| T3/4 versus T1/2 | 1.141 (1.042–1.250) | 0.004 |
| No. LND | ||
| ≥4 versus 1–3 | 1.377 (0.918–2.064) | 0.122 |
| Surgery type | 0.166 | |
| Debulking versus thymectomy | 2.047 (0.864–4.850) | 0.103 |
| Extend thymectomy versus thymectomy | 1.360 (0.869–2.128) | 0.178 |
| Variable . | OR (95% CI) . | P-Value . |
|---|---|---|
| Race | ||
| Other versus white | 0.802 (0.502–1.280) | 0.355 |
| Histology | <0.001 | |
| B3 versus A + AB + B1 + B2 | 3.616 (1.729–7.563) | 0.001 |
| TCs versus A + AB + B1 + B2 | 8.536 (4.569–15.950) | <0.001 |
| TNETs versus A + AB + B1 + B2 | 39.844 (18.803–84.430) | <0.001 |
| T stage | ||
| T3/4 versus T1/2 | 1.141 (1.042–1.250) | 0.004 |
| No. LND | ||
| ≥4 versus 1–3 | 1.377 (0.918–2.064) | 0.122 |
| Surgery type | 0.166 | |
| Debulking versus thymectomy | 2.047 (0.864–4.850) | 0.103 |
| Extend thymectomy versus thymectomy | 1.360 (0.869–2.128) | 0.178 |
CI: confidence interval; OR: odds ratio; LND: lymph node dissection; TCs: thymic carcinomas; TNETs: thymic neuroendocrine tumours.
Multivariable logistic regression analysis on risk factors for lymph node metastasis in the whole cohort
| Variable . | OR (95% CI) . | P-Value . |
|---|---|---|
| Race | ||
| Other versus white | 0.802 (0.502–1.280) | 0.355 |
| Histology | <0.001 | |
| B3 versus A + AB + B1 + B2 | 3.616 (1.729–7.563) | 0.001 |
| TCs versus A + AB + B1 + B2 | 8.536 (4.569–15.950) | <0.001 |
| TNETs versus A + AB + B1 + B2 | 39.844 (18.803–84.430) | <0.001 |
| T stage | ||
| T3/4 versus T1/2 | 1.141 (1.042–1.250) | 0.004 |
| No. LND | ||
| ≥4 versus 1–3 | 1.377 (0.918–2.064) | 0.122 |
| Surgery type | 0.166 | |
| Debulking versus thymectomy | 2.047 (0.864–4.850) | 0.103 |
| Extend thymectomy versus thymectomy | 1.360 (0.869–2.128) | 0.178 |
| Variable . | OR (95% CI) . | P-Value . |
|---|---|---|
| Race | ||
| Other versus white | 0.802 (0.502–1.280) | 0.355 |
| Histology | <0.001 | |
| B3 versus A + AB + B1 + B2 | 3.616 (1.729–7.563) | 0.001 |
| TCs versus A + AB + B1 + B2 | 8.536 (4.569–15.950) | <0.001 |
| TNETs versus A + AB + B1 + B2 | 39.844 (18.803–84.430) | <0.001 |
| T stage | ||
| T3/4 versus T1/2 | 1.141 (1.042–1.250) | 0.004 |
| No. LND | ||
| ≥4 versus 1–3 | 1.377 (0.918–2.064) | 0.122 |
| Surgery type | 0.166 | |
| Debulking versus thymectomy | 2.047 (0.864–4.850) | 0.103 |
| Extend thymectomy versus thymectomy | 1.360 (0.869–2.128) | 0.178 |
CI: confidence interval; OR: odds ratio; LND: lymph node dissection; TCs: thymic carcinomas; TNETs: thymic neuroendocrine tumours.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
